Literature DB >> 18436203

Nanos3 maintains the germ cell lineage in the mouse by suppressing both Bax-dependent and -independent apoptotic pathways.

Hitomi Suzuki1, Masayuki Tsuda, Makoto Kiso, Yumiko Saga.   

Abstract

Cell death in the germ line is controlled by both positive and negative mechanisms that maintain the appropriate number of germ cells and that prevent the possible formation of germ cell tumors. In the mouse embryo, Steel/c-Kit signaling is required to prevent migrating primordial germ cells (PGCs) from undergoing Bax-dependent apoptosis. In our current study, we show that migrating PGCs also undergo apoptosis in Nanos3-null embryos. We assessed whether the Bax-dependent apoptotic pathway is responsible for this cell death by knocking out the Bax gene together with the Nanos3 gene. Differing from Steel-null embryos, however, the Bax elimination did not completely rescue PGC apoptosis in Nanos3-null embryos, and only a portion of the PGCs survived in the double knockout embryo. We further established a mouse line, Nanos3-Cre-pA, to undertake lineage analysis and our results indicate that most of the Nanos3-null PGCs die rather than differentiate into somatic cells, irrespective of the presence or absence of Bax. In addition, a small number of surviving PGCs in Nanos3/Bax-null mice are maintained and differentiate as male and female germ cells in the adult gonads. Our findings thus suggest that heterogeneity exists in the PGC populations and that Nanos3 maintains the germ cell lineage by suppressing both Bax-dependent and Bax-independent apoptotic pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18436203     DOI: 10.1016/j.ydbio.2008.03.020

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  47 in total

1.  Xenopus Nanos1 is required to prevent endoderm gene expression and apoptosis in primordial germ cells.

Authors:  Fangfang Lai; Amar Singh; Mary Lou King
Journal:  Development       Date:  2012-03-07       Impact factor: 6.868

2.  A conserved germline multipotency program.

Authors:  Celina E Juliano; S Zachary Swartz; Gary M Wessel
Journal:  Development       Date:  2010-12       Impact factor: 6.868

Review 3.  Germ Line Versus Soma in the Transition from Egg to Embryo.

Authors:  S Zachary Swartz; Gary M Wessel
Journal:  Curr Top Dev Biol       Date:  2015-08-19       Impact factor: 4.897

4.  c-kit and its related genes in spermatogonial differentiation.

Authors:  Lei Zhang; Jiangjing Tang; Christopher J Haines; Huai L Feng; Liangxue Lai; Xiaoming Teng; Yibing Han
Journal:  Spermatogenesis       Date:  2011-07-01

5.  NANOS2 interacts with the CCR4-NOT deadenylation complex and leads to suppression of specific RNAs.

Authors:  Atsushi Suzuki; Katsuhide Igarashi; Ken-Ichi Aisaki; Jun Kanno; Yumiko Saga
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-02       Impact factor: 11.205

Review 6.  Primordial germ cells in mice.

Authors:  Mitinori Saitou; Masashi Yamaji
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-11-01       Impact factor: 10.005

7.  Targeted expression in zebrafish primordial germ cells by Cre/loxP and Gal4/UAS systems.

Authors:  Feng Xiong; Zhi-Qiang Wei; Zuo-Yan Zhu; Yong-Hua Sun
Journal:  Mar Biotechnol (NY)       Date:  2013-03-28       Impact factor: 3.619

8.  Expression profile of Nanos2 gene in dairy goat and its inhibitory effect on Stra8 during meiosis.

Authors:  X Yao; F Tang; M Yu; H Zhu; Z Chu; M Li; W Liu; J Hua; S Peng
Journal:  Cell Prolif       Date:  2014-10       Impact factor: 6.831

9.  The Nanos3-3'UTR is required for germ cell specific NANOS3 expression in mouse embryos.

Authors:  Hitomi Suzuki; Rie Saba; Aiko Sada; Yumiko Saga
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

10.  Interaction between DMRT1 function and genetic background modulates signaling and pluripotency to control tumor susceptibility in the fetal germ line.

Authors:  Anthony D Krentz; Mark W Murphy; Teng Zhang; Aaron L Sarver; Sanjay Jain; Michael D Griswold; Vivian J Bardwell; David Zarkower
Journal:  Dev Biol       Date:  2013-03-06       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.